Panelists discuss how to approach a 67-year-old man with advanced polycythemia vera who is resistant to hydroxyurea, ...

Shanghai Yao Yuan Biotechnology Ltd., also known as Drug Farm, is advancing a portfolio of immune-modulating therapies for various indications including hepatitis B virus, hepatocellular cancer and a ...

Hematological diseases can cause massive splenomegaly and portal hypertension via portal vein thrombosis, liver infiltration by malignant cells, or in association with NRH. Myelofibrosis.

We hypothesize that BIFNAR mice would be specifically protected from splenomegaly, B cell activation, and ANA production, due to IFN-s known ability to enhance the antibody response.Methods To examine ...

Panelists discuss how risk stratification, symptom burden, and splenomegaly guide treatment decisions for a 68-year-old woman with intermediate-risk myelofibrosis who isn’t interested in transplant.